Impact of Fecal Microbiota Transplantation in Ulcerative Colitis (REBALANCE-UC)

NCT03483246 PHASE3 ACTIVE_NOT_RECRUITING

Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease. UC pathogenesis remains poorly understood but involves an inappropriate immune response toward an unbalanced gut microbiota (called dysbiosis) in predisposed hosts. The purpose of this study is to determine the effect of the fecal microbiota transplantation on UC.

Details

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	PHASE3
Status	ACTIVE_NOT_RECRUITING
Enrolment	150
Start date	Mon Sep 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Mar 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Ulcerative Colitis

Interventions

• Fecal Microbiota Transplantation (FMT)
• Sham-transplantation Placebo

Countries

France